Needham & Company Maintains a 'Buy' on Medidata Solutions (MDSO); Favorable Demand Environment

May 2, 2012 9:05 AM EDT
Get Alerts MDSO Hot Sheet
Price: $52.14 +0.46%

Rating Summary:
    12 Buy, 5 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 20 | New: 54
Trade MDSO Now!
Join SI Premium – FREE
Needham & Company maintains a 'Buy' on Medidata Solutions (NASDAQ: MDSO) price target raised from $30 to $35.

Analyst, Michael Huang, said, "MDSO’s Q1 call was highlighted by accelerating app revenue growth, raised revenue/EPS guidance, more multi-product deals, a strong pipeline, and competitive takeaways. We were particularly impressed that roughly 25% of new customers purchased more than one product (vs. single digit % a year ago), which we believe reflects the credibility of MDSO’s broader platform and product cycles...We are buyers of MDSO given valuation that we see as favorable (2.9x EV/12Revs) and accelerating trends."

FY12 EPS estimate cut from $1.28 to $1.12 and FY13 from $1.56 to $1.49.

For an analyst ratings summary and ratings history on Medidata Solutions click here. For more ratings news on Medidata Solutions click here.

Shares of Medidata Solutions closed at $28.64 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Needham & Company

Add Your Comment